Curriculum Vitae

PROF. DR. RAJA JASMIN BEGUM BINTI RAJA MOHAMED

Professor
  • Department of Medicine
    Faculty of Medicine
  • jazzmeen
  • 0379492429

BIOGRAPHY

Professor Dr. Raja Jasmin is a consultant rheumatologist and the Head of Rheumatology at Universiti Malaya and University Malaya Medical Centre (UMMC). Her areas of expertise include scleroderma, lupus, connective tissue diseases and autoimmune related arthritis. She obtained her advanced subspecialty training in Rheumatology at the Royal Free Hospital, University College of London (UCL), focusing on scleroderma. Her research work in various field of rheumatology was presented in international conferences and published in ISI-indexed peer reviewed journals. Dr Raja Jasmin is also actively involved as principal investigator in rheumatology clinical trials. She is a committee member of Malaysian Society of Rheumatology (MSR) and she has various appointed positions in the Asia Pacific League of Associations for Rheumatology (APLAR) including scientific committee member, co-convenor and steering committee of scleroderma special interest group. She is the founder of Arthritis PPUM Care Fund in UMMC. She is also actively involved as a coordinator of University Malaya Medical Programme (UMMP) curriculum at University Malaya

ACADEMIC QUALIFICATION

  • Subspeciality Training Rheumatology, (Rheumatology)
    Royal Free Hospital, University College London
  • MIntMed, (Internal Medicine)
    Universiti Malaya (um)
  • MBBS, (Medicine and Surgery)
    Manipal Academy of Higher Education (mahe), India

ADMINISTRATIVE DUTIES

  • Coordinator
    17 Jul 2024 - 16 Jul 2026 (Department)
  • Head of Unit
    21 Oct 2023 - 20 Oct 2025 (University Malaya)
  • Menjalankan Fungsi Sebagai Ketua Unit
    01 Mar 2023 - 20 Oct 2024 (Department)
  • Head of Unit
    01 Mar 2023 - 20 Oct 2024 (Department)
  • Committee Members
    01 Jan 2022 - 31 Dec 2023 (Department)
  • Programme Coordinator
    01 Mar 2019 - 31 Dec 2023 (Department of Medicine, Faculty of Medicine)
  • Coordinator
    01 Sep 2015 - 31 Dec 2022 (Department of Medicine, Faculty of Medicine)
  • Head of Unit
    20 Mar 2017 - 20 Mar 2018 (Department of Medicine, Faculty of Medicine)

MEMBERSHIPS

  • APLAR SCLERODERMA SIG CO-CONVENOR, COMMITTEE MEMBER
    2021 to 2025 (International)
  • APLAR STEERING COMMITTEE MEMBER FOR SCLERODERMA SIG, COMMITTEE MEMBER
    2021 to 2025 (International)
  • APLAR MYOSITIS SIG MEMBER, MEMBER
    2021 to 2025 (International)
  • NATIONAL SPECIALIST REGISTER (INTERNAL MEDICINE), MEMBER
    Since 2016 (National)
  • NATIONAL SPECIALIST REGISTER (RHEUMATOLOGY), MEMBER
    Since 2016 (National)
  • PERSATUAN SLE MALAYSIA (PSLEM), MEMBER
    Since 2015 (National)
  • ARTHRITIS FOUNDATION MALAYSIA (AFM), MEMBER
    Since 2015 (National)
  • SCLUM ASIA EXTERNAL ADVISORY BOARD, ADVISORY BOARD
    2022 to 2023 (International)
  • ASIA PACIFIC LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY CONGRESS (APLAR) - SCLERODERMA MYOSITIS SPECIAL INTEREST GROUP , COMMITTEE MEMBER
    2018 to 2023 (International)
  • APLAR SCIENTIFIC COMMITTEE MEMBER, COMMITTEE MEMBER
    2018 to 2023 (International)
  • ILD CONNECT STEERING COMMITTEE MEMBER, COMMITTEE MEMBER
    2022 to 2022 (National)
  • MALAYSIA SOCIETY OF RHEUMATOLOGY (MSR), COMMITTEE MEMBER
    2020 to 2022 (National)
  • ARTHRITIS CARE, PPUM CARE, TREASURER
    2019 to 2022 (National)
  • ASIA PACIFIC LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY CONGRESS (APLAR), COMMITTEE MEMBER
    2018 to 2022 (International)
  • ASIA PACIFIC LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY (APLAR) CENTER OF EXCELLENCE, COMMITTEE MEMBER
    2018 to 2022 (International)
  • MALAYSIA SOCIETY OF RHEUMATOLOGY (MSR), COMMITTEE MEMBER
    2018 to 2022 (National)
  • 21ST MSR-SSR WORKSHOP 2020, ORGANISING COMMITTEE
    2019 to 2020 (International)
  • MALAYSIAN PROTECTION SOCIETY, ORDINARY MEMBER
    2017 to 2020 (National)

AWARD AND STEWARDSHIP

  • Certificate of Excellent Service
    2025, Universiti Malaya
  • Certificate of Excellence Award - Vitalissce™ Study: First National RecrUiTMent
    2023, CIC PPUM,  (National)
  • CIC Awards Appreciation - 1st Hospital in Malaysia to Randomize 1st Patient for "contrast 1" Study.
    2022, CIC UMMC,  (University)
  • First Subject Randomization in Malaysia for Gsk Contrast-1.
    2020, GSK & IQVIA,  (National)
  • Reviewer Service for International Journal of Rheumatic Diseases
    2019, International Journal of Rheumatic Diseases,  (International)
  • Excellence Service Award
    2019, Universiti Malaya
  • Certificate of Appreciation: Coordinator Ummp 3.1
    2017, Department of Medicine, UM,  (Department)
  • Outstanding Performance in The Study 234712 (bi 1199.214 - Senscistm) and Top 1 Recruiter in Malaysia.
    2017, Parexel,  (National)
  • Coordinator Ummp 3.1
    2016, Department of Medicine, UM,  (Department)
  • Runner Up of Young Scientist Award.
    2011, World Congress on Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). Unable to attend,  (International)

PUBLICATIONS

Article in Journal
WoS
  1. Fong, S. Y., Raja, J., Wong, K. T., & Goh, K. J. (2021). Systemic lupus erythematosus may have an early effect on peripheral nerve function in patients without clinical or electrophysiological neuropathy: comparison with age- and gender-matched controls. Rheumatology International, 41(2), 355-360. doi: 10.1007/s00296-020-04610-8
  2. Raja, J., Balaikerisnan, T., Ramanaidu, L. P., & Goh, K. J. (2021). Large fiber peripheral neuropathy in systemic sclerosis: A prospective study using clinical and electrophysiological definition. International Journal of Rheumatic Diseases, 24(3), 347-354. doi: 10.1111/1756-185x.14042
  3. Tan, C. Y., Ambang, T., Raja, J., Shahrizaila, N., Sockalingam, S., Suzuki, S., . . . Goh, K. J. (2021). Immune-mediated necrotizing myopathy in a multi-ethnic Malaysian cohort. Neurology Asia, 26(2), 291-299.
Others
  1. Helicobacter pylori in gastrointestinal manifestation of systemic sclerosis
  2. Lee HJ*, Pok LSL*, Ng CM, Yahya F, Sockalingam S, Tee YC, Raja J. Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients. Int J Rheum Dis. 2020;23:1088 1093. https://doi.org/10.1111/1756-185X.13897 (*co-first authors)
  3. Leela Raman, Fariz Yahya, Choung Min Ng, Sargunan Sockalingam, Kuganathan Ramasamy, Ravinash Ratnam, Jasmin Raja (2020). Early damage as measured by SLICC/ACR damage index is a predictor of hospitalization in systemic lupus erythematosus (SLE). Lupus, Volume: 29 issue: 14, page(s): 1885-1891.
  4. Sue Yng Fong, Jasmin Raja, Kum Thong Wong, Khean Jin Goh. Systemic lupus erythematosus may have an early effect on peripheral nerve function in patients without clinical or electrophysiological neuropathy: comparison with age- and gender-matched controls. Rheumatol Int 2020; Jun 2. doi: 10.1007/s00296-020-04610-8.
  5. Kumutha Gopal, Malathi Thevarajah, Ng Choung Min, Jasmin Raja. Effects of vitamin D on disease activity, functional disability and serum interleukin-6 in rheumatoid arthritis. Int J Rheum Dis 2019 May;22(5):834-841.
  6. Sumaiyah Mat, Mohamad Hasif Jaafar,Ng Chin Teck, Sargunan Sockalingam, Jasmin Raja, Shahrul Bahyah Kamaruzzaman, Chin Ai-Vyrn, Azlina Amir Abbas, Chan Chee Ken, Noran Naqiah Hairi, Sajaratulnisah Othman, Robert Cumming, Nai Peng Tey, Maw Pin Tan (2019). Ethnic differences in the Prevalence, Socioeconomic and Health Related Risk Factors of Knee Pain and Osteoarthritis Symptoms in Older Malaysians. PLOS One
  7. Mat, S., Jaafar, M.H., Sockalingam, S., Raja, J., Kamaruzzaman, S.B., Chin, A.V., Abbas, A.A., Chan, C.K., Hairi, N.N., Othman, S., Cumming, R., Tan, M.P. (2018) Vitamin D deficiency is associated with ethnicity and knee pain in a multi-ethnic South-East Asian nation: Results from Malaysian Elders Longitudinal Research (MELoR). International Journal of Rheumatic Diseases, 21(5),930-936. doi: 10.1111/1756-185X.13279. Epub 2018 Apr 3. PMID: 29611292.
  8. J.Raja, CT Ng, I.Sujau, KF Chin, S.Sockalingam. High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity. Clinical and Experimental Rheumatology (Tier 2). 2016 Sep-Oct;34 Suppl 100(5):115-121
  9. Jasmin Raja, Christopher Paul Denton. Emerging therapies in systemic sclerosis. Indian Journal of Rheumatology. 2016;11:153-63.
  10. *C.Bruni, *J.Raja, C.P Denton, M. Matucci-Cerinic.The clinical relevance of sexual dysfunction in systemic sclerosis. Autoimmunity Reviews. Volume 14, Issue 12, December 2015, Pages 1111 1115 Doi:10.1016/j.autrev.2015.07.016.*First authorship shared.(ISI cited,Tier 1)
  11. Jasmin Raja, Christopher Paul Denton. Cytokines in the immunopathology of systemic sclerosis. Seminars in Immunopathology. Sept 2015, volume 37, issue 5, pp 543- 557. DOI 10.1007/s00281-015-0511-7.(ISI cited, Tier 1)
  12. Jasmin Raja, Svetlana I Nihtyanova, Charles D Murray, Christopher P Denton, Voon H Ong. Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis. Rheumatology (Oxford).2015 Aug 28. doi:10.1093/rheumatology/kev318.(ISI cited, Tier 1)
  13. Khairullah S, Sulaiman H, Yahya F, Jasmin R, Cheah TE, Sockalingam S, Bick J, Chin Teck NG.Cryptococcal meningitis and SLE: a diagnostic and therapeutic challenge.Acta Reumatol Port. 2014 Jul-Sep;39(3):254-8. (ISI cited)
  14. Ng CT, Jasmin R, Cheah TE. Rituximab is not useful in bilateral ocular involvement caused by eosinophilic granulomatosis with polyangiitis. Acta Reumatol Port. 2014 Jul-Sep;39(3):281-2.(ISI cited)
  15. R Jasmin, S Sockalingam, LP Ramanaidu, KJ Goh. Clinical and electrophysiological characteristics of symmetrical polyneuropathy in a cohort of systemic lupus erythematosus patients. Lupus. Published online 24 September 2014. DOI: 10.1177/0961203314552115. (ISI cited, Tier 2)
  16. Sujau I, Ng CT, Sthaneshwar P, Sockalingam S, Cheah TE, Yahya F, Jasmin R. Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort. Int J Rheum Dis. 2014 Feb 23. doi: 10.1111/1756-185X.12322. (ISI cited, Tier 3)
  17. Jasmin R, Ng CT, Sockalingam S, Fariz Y, Cheah TE, Athar S, Myocardial infarction with normal coronaries: an unexpected finding in a 13-year-old girl with systemic lupus erythematosus, Lupus 2013 22:1518-1522, originally published online 4 September 2013 DOI: 10.1177/0961203313503913. (ISI cited, Tier 2)
  18. Jasmin R, Sockalingam S, Cheah TE, Goh KJ, Systemic lupus erythematosus in the multiethnic Malaysian population: disease expression and ethnic differences re-visited, Lupus. 2013 Aug;22(9):967- 71. doi: 10.1177/0961203313496299. Epub 2013 Jul 11. (ISI cited, Tier 2)
  19. Khairullah S, Jasmin R, Yahya F, Cheah TE, Ng CT, Sockalingam S.Chronic intestinal pseudo-obstruction: a rare first manifestation of systemic lupus erythematosus.Lupus. 2013 Aug;22(9):957-60. doi: 10.1177/0961203313492873.(ISI cited, Tier 2)
  20. Ong CS, Cheah TE, Jasmin R, Yahya F, Sockalingam S, Ng CT.Painless ascites and elevated CA125: initial presentation of lupus-associated protein-losing enteropathy.Lupus. 2013 Oct;22(11):1174-7. doi: 10.1177/0961203313498792.(ISI cited, Tier 2)
  21. Yahya F, Jasmin R, Ng CT, Cheah TE, Sockalingam S.Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.Int J Rheum Dis. 2013 Dec;16(6):724-30. doi: 10.1111/1756-185X.12179.(ISI cited, Tier 3)
  22. Yogeswari Venugopal, Shireene Vethakkan, Sargunan Sockalingam, Raja Jasmin, Karen Choong.A CASE OF PERSISTENT HYPOGLYCEMIA: WHEN TO THINK OUTSIDE THE BOX. Clinical Diabetes.Volume 31,Number 3,2013.pg 130- 133
  23. R Jasmin, S Sockalingam, N Shahrizaila, TE Cheah, A Zain, KJ Goh. Successful treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Systemic Lupus Erythematosus (SLE) with oral cyclophosphamide. Lupus. 2012 Sep;21(10):1119-23 (ISI cited, Tier 2)
  24. CHEAH, T. E., JASMIN, R. and SOCKALINGAM, S. (2011), A combination of extraglandular manifestations of Sjogrens syndrome. International Journal of Rheumatic Diseases. doi: 10.1111/j.1756-185X.2011.01636.x (ISI cited, Tier 3)
  25. Mei-Ling Sharon Tai, Tan CT, Ramli N, Begum RJ, Lim SY. Movement disorder in a patient with stroke. Journal of Clinical Neuroscience 2011;18(2);305.(ISI cited)
Chapter in Books
  1. Raja, J., Raja, R. (2022). Carcinomatous Polyarthritis. In: Ravindran, V., Santhanam, S., Goyal, M. (eds) Rarer Arthropathies. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-031-05002-2_17
  2. Jasmin Raja, Voon H Ong. (2019). Antibiotic treatment. Chapter 22, page 183-192. In Marco Matucci-Cerinic and Christopher P. Denton (Eds), Atlas of Ulcers in Systemic Sclerosis. Springer International Publishing.
Article in Proceeding
  1. Jasmin RAJA, Shanthini MUTHUSAMY, Shereen Suyin H NG, Seow Lin CHUAH, Guo Ruey LING, Hooi Chuen HONG, Malehah MOHD NOH, Chiew Gek KHOR, Choung Min NG, Nor Shuhaila SHAHRIL. Survival Of Systemic Sclerosis Patients with Interstitial Lung Disease In Malaysia. APLAR Hong Kong 2022 (Poster)
  2. Thayalan Ponniah, Chee Kuan Wong, Choung Min Ng, Jasmin Raja. Assessment of Health-Related Quality of Life (HRQoL) in Scleroderma (SSc) Interstitial Lung Disease (ILD) patients and its association with clinical parameters. APLAR Hong Kong 2022 (Poster)
  3. APLAR (Asia Pacific League of Rheumatology) congress poster presentation
  4. APLAR congress (Asia Pacific League of Rheumatology)
  5. J. Raja, S. Muthusamy, CM Ng (2021). AB0458 Survival Of Scleroderma Patients With Interstitial Lung Disease: Observation Data From A Malaysian Tertiary Centre. Annals of the Rheumatic Diseases 2021;80:1256.
  6. Early Damage As Measured By Slicc/Acr Damage Index Is A Predictor Of Hospitalization In Systemic Lupus Erythematosus (SLE).
  7. Kumutha Gopal, Malathi Thevarajah, Ng Choung Min, Jasmin Raja. Effects of vitamin D on disease activity, functional disability and serum interleukin-6 in rheumatoid arthritis. Volume 77, Issue Suppl 2, Annals of the Rheumatic Diseases
  8. T. Balaikerisnan, KJ Goh, LP Ramanaidu, J. Raja. Clinical and electrophysiological diagnosis of symmetrical polyneuropathy in systemic sclerosis: study from a single tertiary centre in Malaysia. Poster SAT0494 EULAR 2018. Volume 77, Issue Suppl 2, Annals of the Rheumatic Diseases
  9. Zaki Ariffin, Pavai Sthaneshwar, Jasmin Raja. Audit on Requesting Pattern of ANA And ENA in a Tertiary Care Hospital.
  10. Fong Sue-Yng, et al (2012, June). Nerve Conduction Study Findings in SLE Patients Without Neuropathy Symptoms and Signs. Paper presented at the 13th Asian Oceanian Congress of Neurology (AOCN) in Australia
  11. K.Ramasamy (2015). Risk factors for disease damage as predictors for hospitalisation in systemic lupus erythematosus. Poster presentation in APLAR, 2015 in Chennai, India
Other Publications
  1. #HEALTH: World Arthritis Day - management of RA - October 12, 2022 @ 10:34am - Mass Media(newspaper,radio,tv,popular Magazine)
  2. Beat Arthritis in 360 Digest (Issue 10) - Mass Media(newspaper,radio,tv,popular Magazine)
  3. Diet and nutrition for rheumatoid arthritis. Health (The Vibes). Published on 12 Oct 2022 3:00PM - Mass Media(newspaper,radio,tv,popular Magazine)
  4. Invited guest speaker on TV talk show on Astro Prima Tanya Dr Imelda - Mass Media(newspaper,radio,tv,popular Magazine)
  5. Achy, Creaky, Joint Pain in the Elderly/ Young People Also Susceptible To OA, BERNAMA News - Mass Media(newspaper,radio,tv,popular Magazine)
  6. Arthritis also affects young people - UMMC director, BERNAMA news - Mass Media(newspaper,radio,tv,popular Magazine)
  7. Arthritis also affects young people: UMMC Director, The Sun Daily - Mass Media(newspaper,radio,tv,popular Magazine)
  8. Artritis jangan dipandang ringan - Pakar | Astro Awani - Mass Media(newspaper,radio,tv,popular Magazine)

RESEARCH PROJECT

National
  1. 2020 - 2022, Boehringer Ingelheim education grant
    Quality of life in Scleroderma ILD and its association with clinical parameters in comparison with IPF ( Principal Investigator(PI))
  2. 2020 - 2021, Boehringer Ingelheim education grant
    H. Pylori and gastrooesophageal manifestation in Scleroderma ( Principal Investigator(PI))
  3. 2018 - 2019, Education Grant
    Fatigue and its associated factors in a multi-ethnic cohort of malaysian rheumatoid arthritis patients. ( Principal Investigator(PI))
  4. 2016 - 2017, Arthritis Foundation Malaysia
    Relationship between vitamin D status and interleukin-6 with disease activity in Malaysian patients with rheumatoid arthritis ( Principal Investigator(PI))
  5. 2016 - 2017, NONE
    Prevalence and associated features of peripheral neuropathy in a cohort of Malaysian systemic sclerosis patients in UMMC ( Principal Investigator(PI))
  6. 2011 - 2013, Novartis
    Efficacy and Tolerability of Mycophenolate Sodium in patients with non renal active systemic lupus erythematosus. ( Consultant)
  7. 2012 - 2013, Postgraduate Research Grant(PPP)
    High-resolution manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity. ( Principal Investigator(PI))
  8. 2012 - 2013, Postgraduate Research Grant(PPP)
    Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort. ( Principal Investigator(PI))
  9. 2010 - 2011, Postgraduate Research Grant(PPP)
    Peripheral Neuropathy in SLE in a Multiethnic Malaysian Population ( Principal Investigator(PI))
  10. 2010 - 2011, Postgraduate Research Grant(PPP)
    Systemic lupus erythematosus in the multiethnic Malaysian population: disease expression and ethnic differences revisited. ( Principal Investigator(PI))
International
  1. 2020 - 2022, Abbvie
    Risankizumab Psoriatic Arthritis M16-011 KEEPsAKE1 Clinical trial ( Consultant)
  2. 2019 - 2021, GSK
    A 52-week, phase 3, multicentre, randomised, double blind, efficacy and safety study comparing GSK3196165 with placebo and with tofacitinib, in combination with methotrexate in participants with moderately to severely active rheumatoid arthritis who have an inadequate response to methotrexate. ( Principal Investigator(PI))
  3. 2017 - 2019, Boehringer Ingelheim
    SENSCIS - A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib treatment for at least 52 weeks in patients with Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD) ( Principal Investigator(PI))
  4. 2015 - 2019, Pfizer
    Pulmonary Arterial Hypertension (PAH) Sildanefil clinical trial ( Consultant)
  5. 2017 - 2019, Gilead Science
    Gilead FINCH 3- Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy ( Consultant)
  6. 2011 - 2015, GSK
    BLISS-SC study - A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) ( Consultant)
  7. 2012 - 2012, AstraZaneca
    Prevalence study of gastrointestinal risk factors in patients with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis receiving treatment with non steroidal anti- infLammatory drugs: RATIONAL Study. RATIONAL study. ( Consultant)

PAPER PRESENTED

INVITED SPEAKER
  1. Current practice of management of Connective tissue disease - Interstitial Lung Disease in Asia, Masterclass on Interstitial Lung Disease and Connective Tissue Disease, World Scleroderma Foundation, APLAR, EUSTAR (International) (04 Nov 2023 - 04 Nov 2023)
  2. Learning from evidence & experience with Nintedanib in autoimmune related ILD - A rheumatologist perspective, 7th Interstitial Lung Disease Updates 2023, IPR, KKM, Malaysian Thoracic Society (International) (25 Oct 2023 - 25 Oct 2023)
  3. Decision tree and treatment algorithms for patients with Scleroderma, SCLUM Asia - Scleroderma Preceptorship Program in Asia, Boehringer Ingelheim (International) (23 Dec 2022 - 23 Dec 2022)
  4. Updates on treatment of scleroderma associated gastrointestinal involvement, APLAR - ASIA PACIFIC LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY, APLAR (International) (06 Dec 2022 - 09 Dec 2022)
  5. Changing lives with high quality, affordable biosimilars, Hyrimoz Internal Launch, Sandoz, Novartis (National) (10 Nov 2022 - 10 Nov 2022)
  6. Clinical Relevance of Autoantibodies in Rheumatic Diseases, Closing the Gaps in Autoimmune Rheumatic Disease Diagnosis, Chemopharm (University) (13 Oct 2022 - 13 Oct 2022)
  7. What is Rheumatoid Arthritis?, UMMC Patient Forum on Rheumatoid Arthritis, Johnson & Johnson (University) (24 Sep 2022 - 24 Sep 2022)
  8. Understanding the Diagnosis & Management of Rheumatoid arthritis (RA), Psoriatic arthropathy (PsA), Spondyloarthropathy (SpA), Meet the Expert - Rheumatology, Sandoz, Novartis (National) (26 Aug 2022 - 26 Aug 2022)
  9. Scleroderma Interstitial Lung Disease: Screening and Management, UM Masterclass Workshop, Boehringer Ingelheim and UM (National) (29 Jul 2022 - 29 Jul 2022)
  10. The many faces of Autoimmune Diseases, CPA Australia Health Talk, CPA Australia (Private Institution/research Institution/ Non-government Organization (ngo)) (17 Dec 2020 - 17 Dec 2020)
  11. SSc-ILD: The Malaysian Landscape 2020 , Best of APLAR on Scleroderma , Boehringer Ingelheim (International) (28 Nov 2020 - 28 Nov 2020)
  12. The many faces of Psoriatic Arthritis , Spondyloarthritis & Psoriasis Forum , Novartis (Industry/company) (01 Nov 2020 - 01 Nov 2020)
  13. Kenali pelbagai jenis sakit sendi , World Arthritis Day Webinar Series, Pfizer (Industry/company) (30 Sep 2020 - 30 Sep 2020)
  14. Inflammatory Myopathies (Myositis) , Inflammatory Myopathies (Myositis) , Euroimmun (University) (06 Aug 2020 - 06 Aug 2020)
  15. PAH in Lupus, Managing patients with PAH in connective tissue diseases , Actelion (Others) (05 Dec 2019 - 05 Dec 2019)
  16. Rheumatoid Arthritis: Early Diagnosis & New Era of Treatment Management, GP Medical Symposium 2019, UMSC and Pfizer (National) (29 Sep 2019 - 29 Sep 2019)
  17. Management of Ankylosing Spondylitis, Primary Care & Medical Expert Forum (PRIME 2019), Novartis (National) (28 Jul 2019 - 28 Jul 2019)
  18. Case presentation: Golimumab in Psoriatic Arthropathy, Jade Immunology Summit, Janssen (National) (29 Jun 2019 - 29 Jun 2019)
  19. Rheumatoid Arthritis, Xeljanz 4th Anniversary, Pfizer (Others) (04 Apr 2019 - 04 Apr 2019)
  20. Case presentation: Tofacitinib in RA, Tofacitinib in Rheumatoid Arthritis: Real-Word Experience and Case , Pfizer (Others) (14 Mar 2019 - 14 Mar 2019)
  21. Case presentation Scleroderma myositis, Asia Pacific League of Associations for Rheumatology Congress (APLAR) 2018 , APLAR (International) (06 Sep 2018 - 09 Sep 2018)
  22. Optimizing the Care of SpA Patients with Uveitis , Asian Multidisciplinary Interactive Symposium in Immunology, Abbvie (National) (30 Jun 2018 - 01 Jul 2018)
  23. Peripheral neuropathy in SLE and Scleroderma UMMC data, Malaysian Society of Rheumatology (MSR) Training Day 2018 Theme: Neurological manifestations in Rheumatic Diseases , MSR and UMMC Rheumatology team (National) (11 May 2018 - 11 May 2018)
  24. Lung-dominant connective tissue disease, Malaysian Thoracic Society 2017 , Malaysian Thoracic Society  (National) (15 Jun 2017 - 15 Jun 2017)
  25. A Multifaceted Axial Spondyloarthropathy case, South East Asia Immunology Masterclass 2017 , Janssen (International) (01 Apr 2017 - 02 Apr 2017)
  26. Early detection and management of patients with CTD associated PAH, Malaysian PAH Masterclass 2016 , Actelion (National) (26 Nov 2016 - 26 Nov 2016)
  27. A Multifaceted Axial Spondyloarthropathy Case, Malaysian Society Rheumatology/Singapore Society Rheumatology 2016 , Abbvie (International) (12 Aug 2016 - 12 Aug 2016)
  28. Pulmonary Hypertension in Connective Tissue Diseases, Pulmonary Hypertension workshop in University Malaya, Actelion (University) (30 Jan 2015 - 30 Jan 2015)
EVENT ORGANISER
  1. Organising committee 21st MSR-SSR Rheumatology 2020, Organising committee 21st MSR-SSR Rheumatology 2020, MSR (International) (01 Jan 2019 - 16 Aug 2020)
  2. Event Organiser and Scientific committee for Main congress: Road to Success in Rheumatology, 19th MSR-SSR Workshop in Rheumatology 2018 (Workshop), MSR (International) (03 Aug 2018 - 05 Aug 2018)
POSTER PRESENTER
  1. Assessment of Health-Related Quality of Life (HRQoL) in Scleroderma (SSc) Interstitial Lung Disease (ILD) and its association with clinical parameters., APLAR - ASIA PACIFIC LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY, APLAR (International) (06 Dec 2022 - 09 Dec 2022)
  2. Survival Of Systemic Sclerosis Patients with Interstitial Lung Disease In Malaysia, APLAR - ASIA PACIFIC LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY, APLAR (International) (06 Dec 2022 - 09 Dec 2022)
  3. Survival Of Scleroderma Patients With Interstitial Lung Disease: Observation Data From A Malaysian Tertiary Centre. , APLAR, APLAR (International) (28 Aug 2021 - 31 Aug 2021)
  4. Early Damage As Measured By Slicc/Acr Damage Index Is A Predictor Of Hospitalization In Systemic Lupus Erythematosus (SLE)., European League Against Rheumatism (EULAR) 2020 Congress, EULAR (International) (03 Jun 2020 - 06 Jun 2020)
  5. Fatigue and its associated factors in a multi-ethnic cohort of malaysian rheumatoid arthritis patients., APLAR/ARA 2019 , APLAR (International) (08 Apr 2019 - 11 Apr 2019)
  6. Spectrum in Inflammatory Myopathies in a Multi-ethnic Cohort of Malaysian Patients., Global Conference in Myositis , Global Conference in Myositis (GCOM) (International) (27 Mar 2019 - 30 Mar 2019)
  7. Audit on Requesting Pattern of ANA and ENA in a Tertiary Care Hospital , Asia Pacific League of Associations for Rheumatology Congress (APLAR) 2018, APLAR (International) (06 Sep 2018 - 09 Sep 2018)
  8. Clinical and electrophysiological diagnosis of symmetrical polyneuropathy in systemic sclerosis: study from a single tertiary centre in Malaysia., Annual European Congress of Rheumatology (EULAR) 2018, EULAR (International) (13 Jun 2018 - 16 Jun 2018)
  9. Gastroesophageal manifestations in systemic sclerosis: an evaluation of motility and acid reflux, Asia Pacific League Against Rheumatism (APLAR) Annual Congress 2015 (International) (07 Sep 2015 - 09 Sep 2015)
  10. Risk factors for disease damage as predictors for hospitalisation in systemic lupus erythematosus, Asia Pacific League Against Rheumatism (APLAR) Annual Congress 2015 (International) (07 Sep 2015 - 09 Sep 2015)
  11. Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis. , European League Against Rheumatism (EULAR) 2015 (International) (08 Jun 2015 - 11 Jun 2015)
  12. An observational study of intravenous immunoglobulin therapy in the treatment of gastrointestinal involvement in systemic sclerosis , British Society of Rheumatology (Poster tour), BSR (International) (28 Apr 2015 - 30 Apr 2015)
  13. A woman with Mixed Connective Tissue Disease (MCTD) presenting as resistant hypoglycaemia, Asia Pacific League Against Rheumatism (APLAR) Annual Congress 2012 (International) (11 Sep 2012)
  14. Nerve Conduction Study Findings in SLE Patients Without Neuropathy Symptoms and Signs, 13th Asian Oceanian Congress of Neurology (AOCN)2012 (International) (05 Jun 2012)
  15. The Clinical Profile of Cases of Inflammatory Muscle Disease in UMMC, World Congress on Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD)2012. Unable to attend (International) (19 Jan 2012)
  16. Peripheral Neuropathy in SLE in a Multiethnic Malaysian Population, European League Against Rheumatism (EULAR) 2011 Annual Congress (International) (26 May 2011)
OTHERS
  1. Effects of vitamin D on disease activity, functional disability and serum interleukin-6 in rheumatoid arthritis., Annual European Congress of Rheumatology (EULAR) 2018, EULAR (International) (13 Jun 2018 - 16 Jun 2018)
  2. The Clinical Profile Of Cases Of Inflammatory Muscle Disease In University Malaya Medical Centre (UMMC) , European League Against Rheumatism (EULAR) 2012 (International) (06 Jun 2012 - 09 Jun 2012)
  3. The Clinical And Immunological Profile Of Systemic Lupus Erythematosus (SLE) Patients In A Multiethnic Malaysian Population , European League Against Rheumatism (EULAR)2012 (International) (06 Jun 2012 - 09 Jun 2012)

ACADEMIC/ PROF. SERVICES

Evaluation
  1. (2025) Aplar Scientific Committee Member, International, (External Evaluator)
  2. (2022) Thesis Examiner, University, (External Examiner)
  3. (2022) Examiner for Theory Masters Exam Internal Medicine Part 1, National, (External Examiner)
  4. (2022) Reviewer of Journal Article Ijrd, International, (Reviewer)
  5. (2022) Aplar Centre of Excellence, International, (External Evaluator)
  6. (2022) Abstract Reviewer for Msr Conference, National, (Reviewer)
  7. (2022) Reviewer of Journal Article Bmc Rheumatology, International, (Reviewer)
  8. (2022) Reviewer of Journal Article Bmc Rheumatology, International, (Reviewer)
  9. (2022) Reviewer of Journal Article Ijrd, International, (Reviewer)
  10. (2022) Aplar (asia Pacific League of Associations for Rheumatology) Centre of Excellence, International, (External Evaluator)
  11. (2021) Reviewer of Journal Article, International, (Reviewer)
  12. (2021) Reviewer of Journal Article, International, (Reviewer)
  13. (2021) Reviewer of Journal Article, International, (Reviewer)
  14. (2021) Reviewer of Journal Article, International, (Reviewer)
  15. (2021) Panel Reviewer for Umsc Ca.r.e Fund (research Grant) Cycle 1/2021, University, (Reviewer)
  16. (2021) Reviewer of Journal Article, International, (Reviewer)
  17. (2020) Lupus, (Reviewer)
  18. (2020) Rheumatology International, (Reviewer)
  19. (2020) International Journal of Rheumatic Diseases (IJRD) , (Reviewer)
  20. (2019) Lupus, (Reviewer)
  21. (2019) International Journal of Rheumatic Diseases, (Reviewer)
  22. (2019) Rheumatology International , (Reviewer)
  23. (2019) Arthritis & Rheumatology , (Reviewer)
  24. (2019) International Journal of Rheumatic Diseases, (Reviewer)
  25. (2019) Rheumatology International , (Reviewer)
  26. (2018) International Journal of Rheumatic Diseases, (Reviewer)
  27. (2018) Journal of Gastroenterology and Hepatology (JGH) Open , (Reviewer)
  28. (2018) International Journal of Rheumatic Diseases , (Reviewer)
  29. (2018) International Journal of Rheumatic Diseases, (Reviewer)
  30. (2018) International Journal of Rheumatic Diseases, (Reviewer)
  31. (2018) Rheumatology International, (Reviewer)
  32. (2018) Medicine , (Reviewer)
  33. (2018) Singapore Medical Journal , (Reviewer)
  34. (2018) Reviewer of abstracts for APLAR conference 2018 , (Scientific Committee)
  35. (2018) Journal of Rheumatology, (Reviewer)
  36. (2017) Medicine - reviewer, (Reviewer)
  37. (2017) International Journal of Rheumatic Diseases - reviewer , (Reviewer)
  38. (2017) Immunological Investigations - reviewer, (Reviewer)
  39. (2017) Rheumatology International - reviewer, (Reviewer)
  40. (2017) Seminars in Arthritis and Rheumatism - reviewer , (Reviewer)
  41. (2017) International Journal of Rheumatic Diseases - reviewer , (Reviewer)
  42. (2016) Medicine - reviewer , (Reviewer)
  43. (2016) Clinical Rheumatology - reviewer, (Reviewer)
  44. (2016) Rheumatology International - reviewer , (Reviewer)
  45. (2016) Clinical Rheumatology - reviewer, (Reviewer)
  46. (2015) Rheumatology International (Tier 3)- reviewer, (Reviewer)
  47. (2015) Lupus - reviewer, (Reviewer)
  48. (2015) Rheumatology International (Tier 3)- reviewer, (Reviewer)
  49. (2015) Medicine- Reviewer, (Reviewer)
  50. (2015) Rheumatology International (Tier 3)- Reviewer, (Reviewer)
  51. (2015) International Research Journal of Medicine and Medical Sciences - Reviewer, (Reviewer)
  52. (2014) Rheumatology International (Tier 3)- Reviewer, (Reviewer)
  53. (2014) Rheumatology International (Tier 3)- Reviewer, (Reviewer)
  54. (2014) Lupus (Tier 2)- reviewer, (Reviewer)
  55. (2014) Rheumatology International (Tier 3)- Reviewer, (Reviewer)
  56. (2014) Medicine - Reviewer, (Reviewer)
  57. (2014) International Journal of Rheumatic Diseases (Tier 3)- Reviewer, (Reviewer)
  58. (2014) Rheumatology International (Tier 3)- Reviewer , (Reviewer)
  59. (2013) Pediatrics International - Reviewer (Tier 4), (Reviewer)
  60. (2013) Malaysian Family Physician - Reviewer , (Reviewer)
  61. (2013) Lupus (Tier 2) - Reviewer, (Reviewer)
  62. (2013) Case Reports in Medicine (Hindawi Publishing Corporation)- Reviewer , (Reviewer)
  63. (2013) Arthritis Care and Research (Tier 2) - Reviewer, (Reviewer)
  64. (2013) Journal of Neuroinfectious Diseases - Reviewer, (Reviewer)
Contribution to external organisation
  1. (2023) Sclum Asia External Advisory Board, International, (Expert Advisor)
  2. (2022) Ild (interstitial Lung Disease) Connect Steering Committee Member, National, (Expert Advisor)
  3. (2022) Advisory Board Member, National, (Expert Advisor)
  4. (2022) Aplar Special Interest Group (sig) Steering Committee for Scleroderma Research Database, International, (Technical Advisor)
  5. (2022) Panel for Delphi Process: Aplar Recommendations for Telemedicine in Rheumatology, International, (Expert Advisor)
  6. (2020) Regional PF-ILD Advisory Board, Boehringer Ingelheim
  7. (2020) Advisory board: Current treatment landscape of SLE and LN in Malaysia. Role of Belimumab, GSK
  8. (2020) Taltz PsA Advisory Board , Eli Lilly/Zuellig Pharma
  9. (2019) Tofacitinib ORAL Shift Study and Monotherapy Emerging Asia Advisory Board, Pfizer
  10. (2019) Regional South East Asia & South Korea, ROPU SEASK ILD Advisory Board Meeting, Boehringer Ingelheim
  11. (2018) Asia Pacific League of Associations for Rheumatology Congress (APLAR) - Scleroderma/myositis Special Interest Group, APLAR, International
  12. (2018) Asia Pacific League of Associations for Rheumatology Congress (APLAR) - Scientific Committee, APLAR, International
  13. (2018) Enbrel commercial advisory board , Pfizer
  14. (2018) Malaysian Society of Rheumatology (MSR) Training Day 2018 Theme: Neurological manifestations in Rheumatic Diseases , MSR and Rheumatology unit, PPUM
  15. (2018) Tofacitinib Medical Advisory Board, Pfizer
  16. (2018) PEARL workshop, Malaysian Society of Rheumatology (MSR)
  17. (2017) 4th MSR-SSR Workshop 2018 , Malaysian Society of Rheumatology (MSR)
  18. (2017) Spondyloarthropathy advisory board meeting, Novartis
  19. (2016) Pulmonary Hypertension CPG , Pulmonary Hypertension CPG committee working group of expert panel , National
  20. (2016) Celltrion Asean Expert Group Meeting , Celltrion
  21. (2015) Curriculum and syllabus restructuring for Medicine UMMP 3.1, MERDU
  22. (2015) Vetting committee and coordinator of UMMP 3.1 examination, MERDU
  23. (2013) Rheumatology Training Day , MSR
Contribution to event
  1. (2024) Aplar Lunch Symposium: Advances in Management of Ctd-ild – Evidence Based Approach for Early Antifibrotic Treatment, International, (Panelist/Moderator)
  2. (2024) Facilitator of Mrss Skin Score Aplar Precongress Workshop, International, (Course Facilitator)
  3. (2022) Chairperson in Aplar, International, (Panelist/Moderator)
  4. (2022) Event Organiser, University, (Event Organiser)
  5. (2022) Moderator and Chairperson, National, (Panelist/Moderator)
  6. (2022) Organising Committee, National, (Event Organiser)
  7. (2022) Panelist of Msr Grand Rounds, National, (Panelist/Moderator)
  8. (2022) Chairperson for Pompe Disease Cme, National, (Panelist/Moderator)
  9. (2022) Chief Organiser of Medical Night, University, (Event Organiser)
  10. (2022) Panelist for Msr Grand Rounds, National, (Panelist/Moderator)
  11. (2021) Speaker for Cme Event for Ruka, University, (Panelist/Moderator)
  12. (2021) Chairperson for Virtual Reach: Session 8, National, (Panelist/Moderator)
  13. (2021) Speaker for Medical Crossfire Case Study, International, (Panelist/Moderator)
  14. (2021) Chairperson and Panelist for 21st Ssr-msr Conference, International, (Panelist/Moderator)
  15. (2021) Speaker for 21st Ssr-msr Conference, International, (Panelist/Moderator)
  16. (2021) Speaker for Indonesian Association for Clinical Chemistry (iacc), International, (Panelist/Moderator)
  17. (2021) Speaker for National Rheumatology Symposium, National, (Panelist/Moderator)
  18. (2021) Organising Committee, National, (Event Organiser)
  19. (2021) Speaker for Ild Speakers Forum, International, (Panelist/Moderator)
Media appearance
  1. (2024) Fahami Autoimun, National, (Interview)
  2. (2023) #health: Lupus - a Lifelong "battle" Within (nst), National, (Interview)
  3. (2022) Diet and Nutrition for Rheumatoid Arthritis in Vibes (health), National, (Interview)
  4. (2022) #health: World Arthritis Day - Management of Ra in Nst, National, (Interview)
  5. (2022) Beat Arthritis in 360 Digest (issue 10), National, (Interview)
  6. (2020) Invited Guest Speaker On Tv Talk Show On Astro Prima 2020 -tanya Dr Imelda, National, (Interview)
  7. (2019) Achy, Creaky, Joint Pain in The Elderly, National, (Interview)
Mentoring
  1. (2022) Supervisor of Rheumatology Subspecialty Training, International, (Mentor)

SUPERVISION

Postgraduate Student
Master
  1. (2020) Quality of life in scleroderma ILD and its association with clinical parameters, Thayalan Ponniah
  2. (2019) Requesting Pattern of Antinuclear Antibodies (ANA) and anti-Extractable Nuclear Antigens (ENA) simultaneously by Clinicians in a Tertiary Care Hospital in Malaysia, SUJAU IBRAHIM (University Malaya Medical Centre (ummc) (pusat Perubatan Universiti Malaya)(ppum))
  3. (2019) H. Pylori and gastrointestinal manifestations of systemic sclerosis (scleroderma), Dr Shantini Muthusamy
  4. (2018) Fatigue and disease burden in Rheumatoid Arthritis patients, Dr Lee Hwai Jien
  5. (2018) The assessment of quality of life in scleroderma interstitial lung disease and its association with clinical parameters, Thayalan Ponniah (University Malaya Medical Centre (ummc) (pusat Perubatan Universiti Malaya)(ppum))
  6. (2017) PREVALENCE AND ASSOCIATED FEATURES OF PERIPHERAL NEUROPATHY IN A COHORT OF MALAYSIAN SYSTEMIC SCLEROSIS PATIENTS IN UMMC., DR THARSHANNIA BALAIKERISNAN
  7. (2017) ., Dr. Suad Abdellateif Eltaybe Mohammed (S2100101)
  8. (2017) Gastrointestinal manifestations and Helicobacter Pylori in systemic sclerosis patients, Shanthini K Muthusamy (University Malaya Medical Centre (ummc) (pusat Perubatan Universiti Malaya)(ppum))
  9. (2016) RELATIONSHIP BETWEEN VITAMIN D STATUS AND INTERLEUKIN-6 WITH DISEASE ACTIVITY IN MALAYSIAN PATIENTS WITH RHEUMATOID ARTHRITIS, DR. KUMUTHA GOPAL
  10. (2016) Predictive factors of hospitalization and mortality in a multi-ethnic systemic lupus erythematosus cohort from a single tertiary center, Dr Leela A/P Raman (University Malaya Medical Centre (ummc) (pusat Perubatan Universiti Malaya)(ppum))
  11. (2016) Fatigue and its associated factors in a multi-ethnic cohort of Malaysian rheumatoid arthritis patients from a single tertiary centre, Lee Hwai Jien (University Malaya Medical Centre (ummc) (pusat Perubatan Universiti Malaya)(ppum))
  12. (2014) Relationship between vitamin D status and interleukin-6 with disease activity in Malaysian patients with rheumatoid arthritis, KUMUTHA A/P GOBAL (University Malaya Medical Centre (ummc) (pusat Perubatan Universiti Malaya)(ppum))
  13. (2013) Prevalence and associated features of peripheral neuropathy in a cohort of Malaysian systemic sclerosis patients in UMMC., Tharshannia Balaikerisnan (University Malaya Medical Centre (ummc) (pusat Perubatan Universiti Malaya)(ppum))
  14. (2011) Upper Gastrointestinal Manifestations of Systemic Sclerosis in a UMMC Heterogenous Patient Population, Dr.Sujau Ibrahim
  15. (2009) Clinical and autoantibody profile of systemic sclerosis, Sujau Ibrahim (University Malaya Medical Centre (ummc) (pusat Perubatan Universiti Malaya)(ppum))
Under Graduate Students
  1. (2021) Research elective posting
  2. (2015) Methotrexate induced transaminitis/hepatitis among Asian/Malaysian Rheumatoid arthritis and Psoriatic arthritis patients (audit) (U0401123)
  3. (2013) Risk factors for disease damage as predictors for hospitalisation in systemic lupus erythematosus
  4. (2013) Hospitalisations among SLE patients in University Malaya Medical Centre: a retrospective study of 196 patients
  5. (2012) Dry eyes among Rheumatoid arthritis patients
  6. (2011) Clinical profile of fibromyalgia patients in UMMC, comparison with new criteria

SOCIAL RESPONSIBILITY ACTIVITIES

  • Organising Chairman and Speaker for 2024 Ummc Patient Forum On Systemic Lupus Erythematosus (sle), (01 Jun 2024 - 01 Jun 2024) (National)
  • Patient Forum On Rheumatoid Arthritis, (24 Sep 2022 - 24 Sep 2022) (University)
  • Participant Arthritis Awareness Fun Run, (30 Nov 2019 - 30 Nov 2019)
  • Organiser of Ummc Patient Forum On Rheumatoid Arthritis, (12 Oct 2019 - 12 Oct 2019)
  • Chief Organiser of Arthritis Awareness Fun Run, (02 Jun 2019 - 30 Nov 2019)
  • Organising Chairman of Medical Night 2019, (01 Jan 2019 - 30 Nov 2019)
  • Organising Chairman of Medical Night 2018, (24 Nov 2018 - 24 Nov 2018)
  • Organising Committee for World Arthritis Day Patient Forum On Rheumatoid Arthritis, (13 Oct 2018 - 13 Oct 2018)
  • Organising Committee of Medical Games 2017, (18 Nov 2017 - 18 Nov 2017)
  • Participant of Ankylosing Spondylitis Run (charity Fund Raise for Biologics), (08 May 2017 - 08 May 2017)
  • Committee Member/organiser of UM Medical Night 2017, (02 Jan 2017 - 30 Nov 2017)
  • Committee Member/organiser of UM Medical Night 2016, (01 Jan 2016 - 03 Dec 2016)
  • Scleroderma Family Day At Royal Free Hospital, London, (16 May 2015 - 16 May 2015)
  • Committee Member/organiser of UM Internal Medicine Night 2009, (23 May 2009 - 30 Nov 2009)